Editor’s Note: This article is the fourth in our ongoing series for cannabis investors and lenders. In earlier posts, we explored how historical wholesale price data informs smarter investment decisions Post 1, the key indicators investors should watch for forecasting Post 2, and the growing role of commoditization in cannabis markets Post 3.
This installment shifts focus to the debt providers shaping the industry, examining how independent wholesale price data reduces lending risk and strengthens portfolio outcomes.
Debt providers, from specialized REITs and BDCs to hard-money lenders, operate on one fundamental principle: the borrower’s ability to repay. In the cannabis industry, this principle is challenged by extreme price volatility, which directly impacts a borrower’s cash flow, inventory value, and collateral. These risks drive up the cost of capital (15 to 25% interest rates are common) and push lenders to rely on tight covenants and conservative structures along with a deep focus on risk mitigation.
For lenders seeking to deploy capital responsibly, generic or unvetted data sources are a liability. Independent, third-party wholesale price data is not just an ancillary input, it is the core foundation for managing risk, underwriting deals, and monitoring portfolio health in this complex market.
Lenders use a distinct set of metrics to evaluate cannabis deals, reflecting the industry’s elevated regulatory and financial risk. These key dimensions shape both the structure and the cost of the loan:
Without independent wholesale pricing data, these metrics become speculative. Unvetted data can lead to an artificially inflated projection of future revenues, jeopardizing the lender’s ability to judge opportunities properly and exposing their portfolio to unforeseen risk.
Wholesale price data is central to cannabis underwriting because price volatility directly affects borrower cash flows and inventory collateral value. Lenders use price indices and historical data in several concrete ways:
When lenders commit millions in capital, they need data that is unbiased, defensible, and reliable. Data that can hold up under extreme scrutiny. This is where the credibility Cannabis Benchmarks has established in the legal community provides a unique upper-hand to investors.
As highlighted in our Litigation series, law firms, expert witnesses, and courts rely on our independent third-party data to resolve high-stakes valuation disputes and strengthen expert testimony. This level of trust, that the data can withstand the adversarial environment of a courtroom, ensures that when you use data from Cannabis Benchmarks in your underwriting, you are relying on a gold standard of market reality. Using unvetted data, conversely, subjects the entire lending agreement to dispute and compromises the integrity of the valuation from day one.
The role of price data does not end at closing. It is a critical tool for actively monitoring a loan portfolio:
For debt providers, the path to sustained success in the cannabis industry lies in the disciplined management of price risk. Cannabis Benchmarks provides the essential, verifiable wholesale price data and reporting—the foundation for accurate cash-flow forecasting, objective collateral valuation, and proactive portfolio monitoring. By incorporating this third-party benchmark, lenders move beyond speculation and gain the confidence required to deploy capital effectively in the high-risk, high-reward cannabis debt market.
To start your journey toward more informed investment decisions, we invite you to explore our PREMIUM and ENTERPRISE subscriptions. These solutions offer the spot and historical wholesale cannabis price data you need to build your own robust forecasting models and stay ahead of the curve.
Contact Us to speak with one of our team members.